Brian VanScoy

1.3k total citations
49 papers, 1.1k citations indexed

About

Brian VanScoy is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Brian VanScoy has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 35 papers in Molecular Medicine and 17 papers in Epidemiology. Recurrent topics in Brian VanScoy's work include Antibiotic Resistance in Bacteria (35 papers), Antibiotics Pharmacokinetics and Efficacy (35 papers) and Pneumonia and Respiratory Infections (11 papers). Brian VanScoy is often cited by papers focused on Antibiotic Resistance in Bacteria (35 papers), Antibiotics Pharmacokinetics and Efficacy (35 papers) and Pneumonia and Respiratory Infections (11 papers). Brian VanScoy collaborates with scholars based in United States, United Kingdom and Spain. Brian VanScoy's co-authors include Paul G. Ambrose, Sujata M. Bhavnani, George L. Drusano, Arnold Louie, Alexander J. Lepak, David R. Andes, Jennifer McCauley, Ronald N. Jones, Miao Zhao and Lawrence V. Friedrich and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Brian VanScoy

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian VanScoy United States 19 734 710 533 220 200 49 1.1k
Leonard R Duncan United States 21 589 0.8× 428 0.6× 287 0.5× 272 1.2× 251 1.3× 53 1.0k
Zackery P. Bulman United States 19 700 1.0× 469 0.7× 264 0.5× 141 0.6× 165 0.8× 50 993
Luigi Principe Italy 19 878 1.2× 414 0.6× 273 0.5× 152 0.7× 213 1.1× 63 1.1k
Alessandro Capone Italy 17 838 1.1× 354 0.5× 250 0.5× 122 0.6× 241 1.2× 25 1.0k
Justin R. Lenhard United States 16 527 0.7× 365 0.5× 174 0.3× 96 0.4× 130 0.7× 29 735
M. Carmen Conejo Spain 18 696 0.9× 334 0.5× 247 0.5× 121 0.6× 110 0.6× 39 920
Marisa Winkler United States 14 858 1.2× 534 0.8× 263 0.5× 81 0.4× 155 0.8× 30 951
Steven H. Marshall United States 20 994 1.4× 346 0.5× 288 0.5× 293 1.3× 148 0.7× 60 1.3k
Laura J. Rojas United States 16 746 1.0× 301 0.4× 189 0.4× 118 0.5× 186 0.9× 48 893
M Visalli United States 20 946 1.3× 613 0.9× 538 1.0× 292 1.3× 158 0.8× 32 1.6k

Countries citing papers authored by Brian VanScoy

Since Specialization
Citations

This map shows the geographic impact of Brian VanScoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian VanScoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian VanScoy more than expected).

Fields of papers citing papers by Brian VanScoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian VanScoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian VanScoy. The network helps show where Brian VanScoy may publish in the future.

Co-authorship network of co-authors of Brian VanScoy

This figure shows the co-authorship network connecting the top 25 collaborators of Brian VanScoy. A scholar is included among the top collaborators of Brian VanScoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian VanScoy. Brian VanScoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
VanScoy, Brian, Catherine E. Vincent, Sujata M. Bhavnani, et al.. (2023). 2568. Characterization of Sulopenem Pharmacokinetics-Pharmacodynamics Using a One-Compartment In Vitro Infection Model. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations
2.
Lepak, Alexander J., Jeffrey Hammel, Hélio S. Sader, et al.. (2023). Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial Agents and Chemotherapy. 67(4). e0145222–e0145222. 8 indexed citations
3.
VanScoy, Brian, Catherine E. Vincent, Sujata M. Bhavnani, et al.. (2023). 2569. Pharmacokinetic-Pharmacodynamic Evaluation of Sulopenem Using a Five-Day Hollow-Fiber In Vitro Infection Model. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
4.
Bhavnani, Sujata M., Jeffrey Hammel, Elizabeth A. Lakota, et al.. (2023). Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 67(4). e0221321–e0221321. 12 indexed citations
5.
6.
7.
Theuretzbacher, Ursula, Lindley A. Barbee, Kristie L. Connolly, et al.. (2020). Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities. Clinical Microbiology and Infection. 26(12). 1630–1635. 15 indexed citations
8.
Montero, M., Carla López-Causapé, Brian VanScoy, et al.. (2019). Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones. Journal of Global Antimicrobial Resistance. 18. 37–44. 23 indexed citations
9.
Bhavnani, Sujata M., Jeffrey Hammel, Elizabeth A. Lakota, et al.. (2018). 1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection. Open Forum Infectious Diseases. 5(suppl_1). S427–S428. 1 indexed citations
10.
Zhao, Miao, Alexander J. Lepak, Brian VanScoy, et al.. (2018). In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. Antimicrobial Agents and Chemotherapy. 62(4). 54 indexed citations
11.
Ambrose, Paul G., Olga Lomovskaya, David C. Griffith, Michael N. Dudley, & Brian VanScoy. (2017). β-Lactamase inhibitors: what you really need to know. Current Opinion in Pharmacology. 36. 86–93. 22 indexed citations
12.
13.
14.
VanScoy, Brian, David M. Tenero, Simon Turner, et al.. (2017). Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model. Antimicrobial Agents and Chemotherapy. 61(12). 13 indexed citations
15.
VanScoy, Brian, Jennifer McCauley, Sujata M. Bhavnani, Evelyn J. Ellis‐Grosse, & Paul G. Ambrose. (2016). Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 60(9). 5141–5145. 25 indexed citations
16.
Louie, Arnold, Mariana Castanheira, Weiguo Liu, et al.. (2011). Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases. Antimicrobial Agents and Chemotherapy. 56(1). 258–270. 69 indexed citations
17.
Drusano, George L., et al.. (2011). Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia. Antimicrobial Agents and Chemotherapy. 55(6). 2693–2695. 47 indexed citations
18.
Louie, Arnold, Brian VanScoy, Henry S. Heine, et al.. (2011). Differential Effects of Linezolid and Ciprofloxacin on Toxin Production by Bacillus anthracis in an In Vitro Pharmacodynamic System. Antimicrobial Agents and Chemotherapy. 56(1). 513–517. 16 indexed citations
19.
Louie, Arnold, Henry S. Heine, Kiho Kim, et al.. (2008). Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 52(7). 2486–2496. 29 indexed citations
20.
Mamber, Stephen W., et al.. (2004). The Use of Streptolysin O for the Treatment of Scars, Adhesions and Fibrosis: Initial Investigations Using Murine Models of Scleroderma. SHILAP Revista de lepidopterología. 2(2). 67–87. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonard R Duncan Breakdown of academic impact, for papers by Zackery P. Bulman Breakdown of academic impact, for papers by Luigi Principe Breakdown of academic impact, for papers by Alessandro Capone Breakdown of academic impact, for papers by Justin R. Lenhard Breakdown of academic impact, for papers by M. Carmen Conejo Breakdown of academic impact, for papers by Marisa Winkler Breakdown of academic impact, for papers by Steven H. Marshall Breakdown of academic impact, for papers by Laura J. Rojas Breakdown of academic impact, for papers by M Visalli
Rankless by CCL
2026